SMTL ID : 8uac.1

CATHEPSIN L IN COMPLEX WITH AC1115

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.40 Å

Oligo State

homo-dimer

Ligands

2 x W28: N-[(2S)-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-1H-indole-2-carboxamide(Covalent)

W28.1: 16 residues within 4Å: Chain A: Q.19, G.23, S.24, C.25, W.26, G.61, E.63, N.66, G.67, G.68, L.69, M.70, A.135, M.161, D.162, H.163 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:E.63, A:L.69 Hydrogen bonds: A:Q.19, A:C.25, A:G.68, A:G.68, A:G.68, A:D.162 W28.2: 17 residues within 4Å: Chain B: Q.19, G.23, S.24, C.25, W.26, G.61, E.63, N.66, G.67, G.68, L.69, M.70, A.135, M.161, D.162, H.163, G.164 10 PLIP interactions: 10 interactions with chain B Hydrophobic interactions: B:E.63, B:L.69, B:A.135 Hydrogen bonds: B:Q.19, B:C.25, B:G.68, B:G.68, B:D.162 Water bridges: B:N.66, B:H.163

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Mao, L. et al., Olgotrelvir, a dual inhibitor of SARS-CoV-2 M pro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19. Med (2024)

Release Date

2024-02-07

Peptides

Cathepsin L: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Cathepsin L

Related Entries With Identical Sequence